Feasibility of Mediastinal Radiation Use in HeartMate 3 LVAD Recipients with Cancer

Nausharwan Butt; Farooq H Sheikh

doi:10.14797/mdcvj.1115

Feasibility of Mediastinal Radiation Use in HeartMate 3 LVAD Recipients with Cancer

Methodist Debakey Cardiovasc J. 2023 Jan 23;19(1):15-19. doi: 10.14797/mdcvj.1115. eCollection 2023.

Authors

Nausharwan Butt¹, Farooq H Sheikh²

Affiliations

¹ Einstein Medical Center, Philadelphia, Pennsylvania, US.
² MedStar Heart and Vascular Institute/Georgetown University, Washington, DC, US.

Abstract

The HeartMate 3 left ventricular assist device possesses the unique feature of having its electronics and software located within the housing of the pump, which may predispose it to malfunction from radiation exposure during cancer treatment. We investigated this association in a case series of two patients at our institution.

Keywords: HeartMate LVAD; mediastinal cancer; radiation exposure; stereotactic bone radiation therapy.

Publication types

Case Reports

MeSH terms

Feasibility Studies
Heart Failure* / therapy
Heart-Assist Devices*
Humans
Neoplasms*
Retrospective Studies